161 related articles for article (PubMed ID: 37259026)
21. An effective seven-CpG-based signature to predict survival in renal clear cell carcinoma by integrating DNA methylation and gene expression.
Xu L; He J; Cai Q; Li M; Pu X; Guo Y
Life Sci; 2020 Feb; 243():117289. PubMed ID: 31926254
[TBL] [Abstract][Full Text] [Related]
22. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma.
Chen CC; Chu PY; Lin HY
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154
[TBL] [Abstract][Full Text] [Related]
23. Construction of a Lactate-Related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Kidney Renal Clear Cell Carcinoma.
Sun Z; Tao W; Guo X; Jing C; Zhang M; Wang Z; Kong F; Suo N; Jiang S; Wang H
Front Immunol; 2022; 13():818984. PubMed ID: 35250999
[TBL] [Abstract][Full Text] [Related]
24. Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma.
Luo G; Wang L; Zheng Z; Gao B; Lei C
Eur J Med Res; 2023 May; 28(1):176. PubMed ID: 37189176
[TBL] [Abstract][Full Text] [Related]
25. A New Signature That Predicts Progression-Free Survival of Clear Cell Renal Cell Carcinoma with Anti-PD-1 Therapy.
Lin J; Cai Y; Ma Y; Pan J; Wang Z; Zhang J; Liu Y; Zhao Z
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982415
[TBL] [Abstract][Full Text] [Related]
26. Prognostic implication and immunotherapy response prediction of a costimulatory molecule signature in kidney renal clear cell carcinoma.
Lin G; Yang Y; Feng Q; Zhan F; Sun C; Niu Y; Li G
Immunogenetics; 2022 Jun; 74(3):285-301. PubMed ID: 35119508
[TBL] [Abstract][Full Text] [Related]
27. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
Sun Z; Jing C; Xiao C; Li T; Wang Y
Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
[TBL] [Abstract][Full Text] [Related]
28. Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients.
Fei H; Chen S; Xu C
BMC Cancer; 2021 Apr; 21(1):411. PubMed ID: 33858375
[TBL] [Abstract][Full Text] [Related]
29. A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysis.
Liang B; Zhao J; Wang X
PLoS One; 2017; 12(6):e0180660. PubMed ID: 28662155
[TBL] [Abstract][Full Text] [Related]
30. An
Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
[TBL] [Abstract][Full Text] [Related]
31. Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma.
Zhang Y; Zhuang T; Xin Z; Sun C; Li D; Ma N; Wang X; Wang X
Cells; 2022 Dec; 12(1):. PubMed ID: 36611858
[TBL] [Abstract][Full Text] [Related]
32. Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma.
Khadirnaikar S; Kumar P; Pandi SN; Malik R; Dhanasekaran SM; Shukla SK
Mol Carcinog; 2019 Apr; 58(4):544-553. PubMed ID: 30520148
[TBL] [Abstract][Full Text] [Related]
33. Construction and validation of an autophagy-related long non-coding RNA signature to predict the prognosis of kidney renal papillary cell carcinoma.
Kang Z; Yang J
J Investig Med; 2022 Oct; 70(7):1536-1544. PubMed ID: 35725019
[TBL] [Abstract][Full Text] [Related]
34. A Novel M7G-Related MicroRNAs Risk Signature Predicts the Prognosis and Tumor Microenvironment of Kidney Renal Clear Cell Carcinoma.
Hong P; Du H; Tong M; Cao Q; Hu D; Ma J; Jin Y; Li Z; Huang W; Tong G
Front Genet; 2022; 13():922358. PubMed ID: 35812727
[No Abstract] [Full Text] [Related]
35. Comprehensive analysis of expression profiles and prognosis of TRIM genes in human kidney clear cell carcinoma.
Shen J; Wang R; Chen Y; Fang Z; Tang J; Yao J; Gao J; Zhou W; Chen X
Aging (Albany NY); 2022 May; 14(10):4606-4617. PubMed ID: 35617983
[TBL] [Abstract][Full Text] [Related]
36. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
[No Abstract] [Full Text] [Related]
37. Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma.
Tan D; Miao D; Zhao C; Shi J; Lv Q; Xiong Z; Yang H; Zhang X
BMC Cancer; 2023 Mar; 23(1):264. PubMed ID: 36949462
[TBL] [Abstract][Full Text] [Related]
38. Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma.
Fan Z; Sun X; Li K; Zhang Y; Zuo S; Li C; Wan S; Huang D
Dis Markers; 2022; 2022():9010514. PubMed ID: 36618968
[TBL] [Abstract][Full Text] [Related]
39. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract][Full Text] [Related]
40. A Novel Prognostic Signature Associated With the Tumor Microenvironment in Kidney Renal Clear Cell Carcinoma.
Pei D; Xu C; Wang D; Shi X; Zhang Y; Liu Y; Guo J; Liu N; Zhu H
Front Oncol; 2022; 12():912155. PubMed ID: 35860566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]